Epigenetic and genetic features of 24 colon cancer cell lines
about
Clinical significance of HOTAIR expression in colon cancerPractical aspects of NGS-based pathways analysis for personalized cancer science and medicineDendritic cell-based cancer immunotherapy for colorectal cancerCancer Cell Line Panels Empower Genomics-Based Discovery of Precision Cancer MedicineHER2 activating mutations are targets for colorectal cancer treatmentGuanylyl cyclase C signaling axis and colon cancer preventionThe BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotypeA synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancersRepurposing the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic agent for intestinal polyposisAberrant Apoptotic Response of Colorectal Cancer Cells to Novel Nucleoside AnaloguesFunctional Characterization and Drug Response of Freshly Established Patient-Derived Tumor Models with CpG Island Methylator PhenotypeLRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner.SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancerMusashi-1 promotes a cancer stem cell lineage and chemoresistance in colorectal cancer cells.ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer.Dietary mastic oil extracted from Pistacia lentiscus var. chia suppresses tumor growth in experimental colon cancer models.Proteomic and functional investigation of the colon cancer relapse-associated genes NOX4 and ITGA3Novel RNA variants in colorectal cancers.Phosphatidylinositol 3-kinase CB association with preoperative radiotherapy response in rectal adenocarcinomaHigh frequency of fusion transcripts involving TCF7L2 in colorectal cancer: novel fusion partner and splice variants.Identification of subgroup-specific miRNA patterns by epigenetic profiling of sporadic and Lynch syndrome-associated colorectal and endometrial carcinoma.Molecular subtypes in stage II-III colon cancer defined by genomic instability: early recurrence-risk associated with a high copy-number variation and loss of RUNX3 and CDKN2A.Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas.Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling.Inhibition of autophagy exerts anti-colon cancer effects via apoptosis induced by p53 activation and ER stress.Personalized targeted therapy for esophageal squamous cell carcinoma.Acquired resistance to decitabine and cross-resistance to gemcitabine during the long-term treatment of human HCT116 colorectal cancer cells with decitabine.Echinacoside Induces Apoptosis in Human SW480 Colorectal Cancer Cells by Induction of Oxidative DNA Damages.Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.Highly sensitive detection of the PIK3CA (H1047R) mutation in colorectal cancer using a novel PCR-RFLP methodDistinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S PhasePro-survival responses to the dual inhibition of anti-apoptotic Bcl-2 family proteins and mTOR-mediated signaling in hypoxic colorectal carcinoma cellsNetwork modelling reveals the mechanism underlying colitis-associated colon cancer and identifies novel combinatorial anti-cancer targets.Long-lasting reduction in clonogenic potential of colorectal cancer cells by sequential treatments with 5-azanucleosides and topoisomerase inhibitors.Factor inhibiting HIF1α (FIH-1) functions as a tumor suppressor in human colorectal cancer by repressing HIF1α pathway.The effects of a novel aliphatic-chain hydroxamate derivative WMJ-S-001 in HCT116 colorectal cancer cell death.Continuous treatment with FTS confers resistance to apoptosis and affects autophagy.Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms.Antitumor Activity of HM781-36B, alone or in Combination with Chemotherapeutic Agents, in Colorectal Cancer CellsERK mediated upregulation of death receptor 5 overcomes the lack of p53 functionality in the diaminothiazole DAT1 induced apoptosis in colon cancer models: efficiency of DAT1 in Ras-Raf mutated cells.
P2860
Q28334584-B70B0E19-31F2-49D5-8440-96E903E012C8Q28334700-89752C58-CCA1-41BE-B768-48ACDA3E8A38Q28472974-6AA77392-FE95-4214-99C5-DCE8C675E83EQ28519412-B9FA0B98-C23B-4D7C-93E7-34AB3B82684AQ5016050-E63D4C95-62B1-4DE8-85DE-52A1F3C8EEBBQ54749147-0DAC6329-EF52-486D-894F-A984BAE74977Q54813921-80C3729C-0A96-4B11-8498-A3379823E918Q54814087-E261B2CD-1D65-478B-A037-A1EA4F855692Q54831148-A8F5B6C6-87A5-40A6-9F83-2969B65DEE79Q54831736-2859EF7D-2956-464E-B980-BF13CE536753Q54835164-814EEAB5-8758-48E0-838F-411CA28C7966Q54882006-41A63EAB-FBFA-4913-BB13-03C916283BE6Q54898325-239B81A4-3176-4812-B0AF-6FB8A8A45D8AQ54898326-7B6DAFE0-0398-429B-8864-199373A0822AQ54898327-96DF58E5-F80E-4E0B-BEF5-09CB44951074Q54902894-FC3E9CF1-30C2-4649-A1CC-6A55FA627F22Q54903040-C0D13291-93C6-4F59-96C1-36F55B83325FQ54903053-88501D36-4E75-4F4D-8998-63EE3B40B832Q54908070-C40C45E4-5585-48F8-9CE1-4D80B473C3BBQ54950538-26D3481F-B3DD-466E-A686-DFE770ED8B0FQ54971073-8E159942-FFEB-4732-9B3F-5B9937AE7025Q54971115-1EA8C31A-EF97-4F4F-807D-65E80A7403B3Q54971218-5E6B13F5-4DE9-48F7-A2E2-BB1A956C6399Q54971841-CB234B1C-8B13-410C-B751-07A92929B98CQ54971843-A3681D44-666B-4113-83D1-EA3C86DB8276Q54992840-69CD9E50-7EF2-4B09-BD96-29171A2AA042Q54994056-C9A9494D-3BD1-4574-9396-133FA11D6B6C
P1343
Q24658458-BAEFC0AD-A9DD-4A0B-833C-703B5C2F2DD6Q26748603-326CD4E9-85DA-48D1-9B94-740BC074E6E7Q26751339-C4C93631-4152-43EA-B888-36231AAE1ABBQ26800337-FDF1F7DD-785D-43B9-BED6-7956AFBF9E09Q27853193-341F03A2-E190-4FE9-803D-701B591C2296Q28074181-A58144E2-78F9-4041-8296-6448197B46CEQ28247866-9CA4EF11-B8ED-4B58-B1D6-D33D1F74BD2BQ28271944-37261E6D-3181-430F-B77F-0A35A8326D44Q28540528-65E735C2-FAEA-4C05-B7B9-AEF627B17741Q28548303-2AB097C8-3E0C-416D-812A-BECD711FF589Q28551197-58E0EDC7-A27B-443C-9359-D26180C57F2EQ30316110-5CAD1642-2033-4C5F-B7A8-C7680C233AA4Q30842687-DA60D190-ADF5-4BCF-9119-BDDBA9C60A5EQ33708609-9A5ACA6A-99AA-49C2-BD0F-AAEFD3B08768Q33779292-84F93BE2-765F-4372-AF5D-29D147A59B5FQ33812450-BB43A9E6-DFE6-4C93-8253-ECC082E3591EQ34488582-E0D0D070-C787-479C-A02A-86F9C850DE36Q34498285-9E65C75C-9624-41BF-8C10-39023A02254BQ34552147-123504AC-FE70-4CBB-AD9E-79B60F179243Q35114876-663C87CB-80BA-469F-A75E-4B454B99F53CQ35169860-7DE469DF-F825-4CD3-A89E-D74216E90FAAQ35447606-80E217E9-4BED-4514-A16F-9DC8AF2CE268Q35751045-D21258B0-9B3C-4954-9BAB-C37612BAC35AQ35792269-8BCA4E17-927D-44DB-A817-7D9D08FEBFE4Q35819410-08A4D4AF-6F0E-401A-B1D8-08F8FAE48092Q35819517-2F1908B0-680E-4484-863E-1164BFF62AE0Q35870211-2B13B3BC-D645-419B-8F63-D6D4B04258E5Q35902424-7E5E304A-AD60-4DEC-9763-5AEC1485A315Q35979303-06EA9E24-24C7-4EB1-98D8-E6CE79D07565Q36074183-5767F8F9-FA56-4657-A799-763450B28A0CQ36075291-C8C55C8E-E987-4374-8F69-CDFB5613C306Q36086722-E8694AFA-2356-4932-862C-CB0216E607F9Q36134211-F73440F7-9D72-494A-A853-1DD2752E8D1CQ36194410-2FDD9841-B0FD-4B4B-B9D4-DA35A15E3F9EQ36212856-2F96E040-2190-4789-8888-2027A4706728Q36221605-5D4B3649-B98F-4B20-9667-E58ECFDE223AQ36267411-FE5EF84D-6C3E-44FE-BF5B-76C7C833A171Q36408417-9990E9EC-CC39-4E68-B647-0039110F3F65Q36482500-D8D0B567-6122-444D-81B8-39025671404CQ36662230-44138ED3-10DC-4630-A996-6561CEE068A9
P2860
Epigenetic and genetic features of 24 colon cancer cell lines
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epigenetic and genetic features of 24 colon cancer cell lines
@en
Epigenetic and genetic features of 24 colon cancer cell lines.
@nl
type
label
Epigenetic and genetic features of 24 colon cancer cell lines
@en
Epigenetic and genetic features of 24 colon cancer cell lines.
@nl
prefLabel
Epigenetic and genetic features of 24 colon cancer cell lines
@en
Epigenetic and genetic features of 24 colon cancer cell lines.
@nl
P2093
P2860
P4510
P356
P1433
P1476
Epigenetic and genetic features of 24 colon cancer cell lines
@en
P2093
I A Eilertsen
S A Danielsen
P2860
P2888
P356
10.1038/ONCSIS.2013.35
P577
2013-09-16T00:00:00Z
P5875
P6179
1047315575